Sanofi-Aventis

Beyfortus Launch- the dawn of a new era in Soutf Africa

The launch of Beyfortus was doen excellently BTW Prof Zar. She made those challenging statistics like a walk in the dark. The message is clear RSV that causes LRTI will be stopped in its tracks this year. The product, Beyfortus , is pre-filled syringe of 50mg for newborns <5kg, and 100mg pre'filled syringe for >5kg. In South Africa it launched last night. May this initiative save the lives our most vulnerable. In the other countries where this programme is rolled out in Chile, Argentina, France,Australia. South and North America and Spain. If the tide of Health care change , it will benefit even the poorest. If we can have our final trimester mom and newborn baby vaccinated, we have already save our most vulnerable. A pre-filled syringe of 50mg Nursitemab for babies <5kg and 100mg Nursitemab for your >5kg baby.Thank you for all the hard work into making this info so user-friendly. We left the President's Hotel delightfully satisfied. We met new friends had good company, good food and great background music. Let's make a toast to longevity in the lives of your most vulnerable, (newborns,the elderly and sick adults). The immunization will cover the individual for the 5months when RSV LFTI are prevalent. Our babies and most vulnerable now has a better chance of survival. It's is our hope and desire that our government will adopt this immunization of a third trimester mom and newborns as a National Health Program,fully budgeted and roll-out ready. Thank you to the team of scientists working in the background to help save the precious life's of our children. Your efforts are noted.